Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients

Journal of Cardiovascular Magnetic Resonance

Volumn 19, Issue 1, 2017, Pages 1-11

  Ide, Seiko ^a   Riesenkampff, Eugenie ^a   Chiasson, David A ^a   Dipchand, Anne I ^a   Kantor, Paul F ^a,b   Chaturvedi, Rajiv R ^a   Yoo, Shi Joon ^a   Grosse Wortmann, Lars ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b STOLLERY CHILDREN S HOSPITAL   (Canada)

Author keywords

Cardiovascular magnetic resonance; Diffuse myocardial fibrosis; Extracellular volume fraction; Histological validation; Native T1 time; Paediatric heart transplantation

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; BIOLOGICAL MARKER; COLLAGEN; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADOLESCENT; ANTIBODY MEDIATED REJECTION; ARTICLE; CARDIAC GRAFT REJECTION; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; COLLAGEN VOLUME FRACTION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; EXTRACELLULAR VOLUME FRACTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; ISCHEMIA TIME; MALE; NATIVE T1 TIME; NUCLEAR MAGNETIC RESONANCE SCANNER; PROSPECTIVE STUDY; RADIOLOGICAL PARAMETERS; VALIDATION STUDY; AGE; BIOPSY; CARDIAC MUSCLE; CARDIOMYOPATHY; CASE CONTROL STUDY; CHEMISTRY; CINE MAGNETIC RESONANCE IMAGING; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; FIBROSIS; HEART VENTRICLE REMODELING; OBSERVER VARIATION; PATHOLOGY; PATHOPHYSIOLOGY; PILOT STUDY; PREDICTIVE VALUE; PRESCHOOL CHILD; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; BIOMARKERS; BIOPSY; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLLAGEN; CONTRAST MEDIA; FEMALE; FIBROSIS; GADOLINIUM DTPA; HEART TRANSPLANTATION; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIUM; OBSERVER VARIATION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 85011347822     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-017-0326-x     Document Type: Article

References (50)

1. Dipchand AI, Kirk R, Mahle WT, Tresler MA, Naftel DC, Pahl E, et al. Ten yr of pediatric heart transplantation: a report from the pediatric heart transplant study. Pediatr Transplant. 2013;17:99-111.
2. Dipchand AI, Rossano JW, Edwards LB, Kucheryavaya AY, Benden C, Goldfarb S, et al. The registry of the international society for heart and lung transplantation: eighteenth official pediatric heart transplantation report - 2015; focus theme: early graft failure. J Hear Lung Transplant. 2015;34:1233-43.
3. Hiemann N, Wellnhofer E, Lehmkuhl H, Knosalla C, Hetzer R, Meyer R. Everolimus prevents endomyocardial remodeling after heart transplantation. Transplantation. 2011;92:1165-72.
4. Yamani MH, Haji SA, Starling RC, Tuzcu EM, Ratliff NB, Cook DJ, et al. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome. J Am Coll Cardiol. 2002;39:970-7.
5. Pichler M, Rainer PP, Schauer S, Hoefler G. Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin. J Am Coll Cardiol. 2012;59:1008-16.
6. Perens G, Li F, Meier S, Kaur R, Alejos J, Fishbein M. Clinico-pathologic findings in end-stage pediatric heart transplant grafts. Pediatr Transplant. 2009;13:887-91.
7. Skowronski EW, Epstein M, Ota D, Hoagland PM, Gordon JB, Adamson RM, et al. Right and left ventricular function after cardiac transplantation. Changes during and after rejection. Circulation. 1991;84:2409-17.
8. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation. 2005;111:2837-49.
9. Berk B, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Investigation. 2007;117:568-75.
10. Kobashigawa JA, Itagaki BK, Razi RR, Patel JK, Chai W, Kawano MA, et al. Correlation between myocardial fibrosis and restrictive cardiac physiology in patients undergoing retransplantation. Clin Transplant. 2013;27:679-84.
11. Butler CR, Kumar A, Toma M, Thompson R, Chow K, Isaac D, et al. Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes. Can J Cardiol. 2013;29:1076-83.
12. Kozak M, Redington A, Yoo S-J, Seed M, Greiser A, Grosse-Wortmann L. Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study. Pediatr Radiol. 2014;44:403-9.
13. Dusenbery SM, Jerosch-Herold M, Rickers C, Colan SD, Geva T, Newburger JW, et al. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. J Am Coll Cardiol. 2014;63:1778-85.
14. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.
15. Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology. 2001;218:703-10.
16. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138-44.
17. Riesenkampff E, Chen CK, Kantor PF, Greenway S, Chaturvedi RR, Yoo SJ, et al. Diffuse myocardial fibrosis in children after heart transplantations: a magnetic resonance T1 mapping study. Transplantation. 2015;99:2656-62.
18. Miller CA, Sarma J, Naish JH, Yonan N, Williams SG, Shaw SM, et al. Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy. J Am Coll Cardiol. 2014;63:799-808.
19. Ellims AH, Shaw JA, Stub D, Iles LM, Hare JL, Slavin GS, et al. Diffuse myocardial fibrosis evaluated by post-contrast T1 mapping correlates with left ventricular stiffness. J Am Coll Cardiol. 2014;63:1112-8.
20. Coelho-Filho OR, Shah R, Lavagnoli CF, Barros JC, Neilan TG, Murthy VL, et al. Myocardial tissue remodeling after orthotopic heart transplantation: a pilot cardiac magnetic resonance study. Int J Cardiovasc Imaging. 2016. doi:10.1007/s10554-016-0937-6.
21. Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart. 2013;99:932-7.
22. Sibley CT, Noureldin RA, Gai N, Nacif MS, Liu S, Turkbey EB, et al. T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology. 2012;265:724-32.
23. de Meester de Ravenstein C, Bouzin C, Lazam S, Boulif J, Amzulescu M, Melchior J, et al. Histological validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T. J Cardiovasc Magn Reson. 2015;17:1-11.
24. Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013;6:373-83.
25. Lee SP, Lee W, Lee JM, Park EA, Kim HK, Kim YJ, et al. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. Radiology. 2015;274:359-69.
26. Ausdem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2015;16:210-6.
27. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation. 2012;126:1206-16.
28. Schelbert EB, Piehler KM, Zareba KM, Moon JC, Ugander M, Messroghli DR, et al. Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc. 2015. doi:10.1161/JAHA.115.002613.
29. Grosse-Wortmann L, Roche S, Yoo S-J, Seed M, Kantor P. Early changes in right ventricular function and their clinical consequences in childhood and adolescent dilated cardiomyopathy. Cardiol Young. 2010;20:418-25.
30. Messroghli D, Radjenovic A, Kozerke S, Higgins D, Sivananthan M, Ridgway J. Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004;52:141-6.
31. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002;18:539-42.
32. Orwat S, Diller GP, Kempny A, Radke R, Peters B, Kuhne T, et al. Myocardial deformation parameters predict outcome in patients with repaired tetralogy of Fallot. Heart. 2016;102:209-15.
33. Hundley WG, Bluemke D, Bogaert JG, Friedrich MG, Higgins CB, Lawson MA, et al. Society for cardiovascular magnetic resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson. 2009;11:5.
34. Hadi AM, Mouchaers KT, Schalij I, Grunberg K, Meijer GA, Vonk-Noordegraaf A, et al. Rapid quantification of myocardial fibrosis: a new macro-based automated analysis. Cell Oncol (Dordr). 2011;34:343-54.
35. Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy differences in complication rate and diagnostic performance. Circulation. 2010;122:900-9.
36. Chen CA, Dusenbery SM, Valente AM, Powell AJ, Geva T. Myocardial ECV fraction assessed by CMR is associated with type of hemodynamic load and arrhythmia in repaired tetralogy of fallot. JACC Cardiovasc Imaging. 2016;9:1-10.
37. Rogers T, Dabir D, Mahmoud I, Voigt T, Schaeffter T, Nagel E, et al. Standardization of T1 measurements with MOLLI in differentiation between health and disease--the ConSept study. J Cardiovasc Magn Reson. 2013;15:78.
38. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley C, et al. T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson. 2012;14:1-10.
39. Dabir D, Child N, Kalra A, Rogers T, Gebker R, Jabbour A, et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the international T1 multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2014;16:69.
40. Dobson G, Cieslar J. Intracellular, interstitial and plasma spaces in the rat myocardiumin vivo. J Mol Cell Cardiol. 1997;29:3357-63.
41. Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Choudhury RP, et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14:1-12.
42. Pickering JG, Boughner DR. Fibrosis in the transplanted heart and its relation to donor ischemic time. Assessment with polarized light microscopy and digital image analysis. Circulation. 1990;81:949-58.
43. Armstrong A, Binkley P, Baker P, Myerowitz PD, Leier C. Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation. J Am Coll Cardiol. 1998;32:704-10.
44. Gramley F, Lorenzen J, Pezzella F, Kettering K, Himmrich E, Plumhans C, et al. Hypoxia and myocardial remodeling in human cardiac allografts: a time-course study. J Hear Lung Transplant. 2009;28:1119-26.
45. Hiemann NE, Wellnhofer E, Knosalla C, Lehmkuhl HB, Stein J, Hetzer R, et al. Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies. Circulation. 2007;116:1274-82.
46. Ahn J, Kim J. Mechanisms and consequences of inflammatory signaling in the myocardium. Curr Hypertens Rep. 2012;14:510-6.
47. Riesenkampff E, Luining W, Seed M, Chungsomprasong P, Manlhiot C, Elders B, et al. Increased left ventricular myocardial extracellular volume is associated with longer cardiopulmonary bypass times, biventricular enlargement and reduced exercise tolerance in children after repair of tetralogy of fallot. J Cardiovasc Magn Reson. 2016;18:75.
48. Shah AM, Claggett B, Sweitzer NK, Shah SJ, Deswal A, Anand IS, et al. Prognostic importance of changes in cardiac structure and function in heart failure with preserved ejection fraction and the impact of spironolactone. Circ Heart Fail. 2015;8:1052-8.
49. Eleid MF, Caracciolo G, Cho E, Scott RL, Steidley ED, Wilansky S, et al. Natural history of left ventricular mechanics in transplanted hearts: relationships with clinical variables and genetic expression profiles of allograft rejection. J Am Coll Cardiol Img. 2010;3:989-1000.
50. Kailin JA, Miyamoto SD, Younoszai AK, Landek BF. Longitudinal myocardial deformation is selectively decreased after pediatric cardiac transplantation: a comparison of children 1 year after transplantation with normal subjects using velocity vector imaging. Pediatr Cardiol. 2012;33:749-56.